Sonoma Pharmaceuticals
SNOA
SNOA
21 hedge funds and large institutions have $1.82M invested in Sonoma Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less capital invested
Capital invested by funds: $2.73M → $1.82M (-$909K)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$79.9K | |
| 2 | +$68K | |
| 3 | +$35K | |
| 4 |
BA
Bard Associates
Chicago,
Illinois
|
+$24.1K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.2K |
Top Sellers
| 1 | -$255K | |
| 2 | -$74K | |
| 3 | -$41K | |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$8.07K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$4K |